SHINE7hOpinion
China's biotech boom is reshaping the global pharmaceutical landscape
With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...
Stricter abortion laws may cause increased infant deaths − 2 maternal and child health researchers explain the data
Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...
Pharmabiz13h
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...
Santhera Announces Chief Financial Officer Transition with Appointment of Catherine Isted
Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, appointed as CFO effective February 24, 2025Current CFO ...
National Institute for Health and Care Excellence7d
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer
Pembrolizumab (Keytruda, Merck Sharp & Dohme) is indicated for 'the adjuvant treatment of adults with non-small cell lung carcinoma who are at high risk of recurrence following complete resection and ...
Medscape13d
Postoperative RT Plus Cetuximab Showed Mixed Results in Head and Neck Cancer Trial
Patients with squamous cell carcinoma of the head and neck were randomly assigned to receive either intensity-modulated ...
Cancer Therapy Advisor2d
Pembrolizumab Provides “Robust” Clinical Benefit in Clear Cell Gynecologic Cancer
Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.
Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...
Santhera Pharmaceuticals Holding AG: Santhera Announces Chief Financial Officer Transition with Appointment of Catherine Isted
Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, appointed as CFO effective February 24, 2025Current CFO Andrew Smith to step down after five years with Santhera, an ...